Episode Description
Traditionally, vaccines have been designed to prevent infectious diseases. But what if a vaccine could help the immune system recognize and attack cancer that is already there?
Enter SurVaxM: an experimental vaccine developed for glioblastoma, one of the most aggressive and difficult-to-treat forms of brain cancer.
In this episode, Hajar speaks with Roswell Park researcher Michael Ciesielski, who helped create SurVaxM. They explore how the vaccine was developed, how it works alongside standard glioblastoma treatments, and how it could potentially be used to treat, or even help prevent, other cancers.
Keep up with all things Smarter Than Cancer and let us know what you think of the show at https://www.roswellpark.org/smarterthancancer.



























